Anastrozole

Anastrozole Structural formula: C17H19N5 Molecular weight: 29337 CAS NO: 120511-73-1 Appearance: an off-white color crystalline powder Use: It can be used to the treatment of Breast cancer Standard: Enterprise Standard Package: 25KG/Drum 1. Anastrozole is an aromatase-inhibiting drug approved for treatment of breast cancer after surgery, as well as formetastasis in both pre and postmenopausal women. 2. The severity of breast cancer is increased by estrogen, as sexhormones cause hyperplasia, and differentiation at estrogen receptor sites. Anastrozole works by inhibiting the synthesis of estrogen. The trial suggested that anastrozole is the preferred medical therapy for Postmenopausal women with localized breast cancer that is estrogen receptor (ER) positive. 3. Three azole potent selective aromatase inhibitors, which inhibit rely on aromatase cytochrome P -450 to block estrogen biosynthesis, and the main factors of estrogen to stimulate breast cancer cell growth. It can treat breast cancer, especially suitable for those who relapse after treatment with hormone auxiliary advanced breast cancer after menopause women.